Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nextleaf Solutions Ltd C.OILS

Alternate Symbol(s):  OILFF

Nextleaf Solutions Ltd. is a Canada-based company, which is a federally regulated manufacturer and distributor of cannabis vapes and oils under its brand, Glacial Gold. The Company is a cannabis extractor and processor, with a focus on developing intellectual property for the extraction, distillation formulation, and delivery of cannabinoids. It commercializes its intellectual property portfolio through IP licensing, production of cannabidiol (CBD) and tetrahydrocannabinol (THC) oils, through its subsidiary, Nextleaf Labs Ltd. (Labs), and selling products through provincial distribution boards for the adult-use market under the brand Glacial Gold. It sells its branded products to government distributors and authorized retailers in four provinces in Canada. Its patented ingredient processing technology transforms unsold cannabis and hemp biomass into distillate at an industrial scale. Its other subsidiary is Nextleaf Innovations Ltd., which operates as an extraction solutions company.


CSE:OILS - Post by User

Post by Buyhigheatchipson Jan 26, 2022 11:25am
143 Views
Post# 34362369

Hypothetical

Hypothetical

What happens if someone offers us $2 a share on the basis of GG and the extraction tech? Many shareholders may be happy with that but the company doesn't want to give away the specialty molecule IP. How to navigate such a situation?

One thought I had is that another corporation is set up to hold a certain percentage of royalties on that IP and each shareholder gets shares in that corp as part of the deal. 

The other option is to hold out until the speciality molecule IP has been more developed I suppose. 

What do y'all think?
 


 

<< Previous
Bullboard Posts
Next >>